Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

ONCY Stock Annual Cash Flow. Download in Excel

Oncolytics Biotech Inc. logo

Oncolytics Biotech Inc.

Sector: Healthcare   

Industry: Biotechnology

1.28
 
USD
  
0.03
  
(2.40%)
Previous close: 1.25  Open: 1.27  Bid: 1.23  Ask: 1.3
52 week range    
0.84   
   1.80
Mkt Cap: 95 M  Avg Vol (90 Days): 376,083
Peers   
AEZS / 
LLY / 
BMY / 
TEVA / 
AVEO / 
MRTX / 
HBP-CA / 
Last updated: Friday 18th October 2024

Stock Rankings

76
Technical
31
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Financials

ONCY Cash Flow

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
(Increase) Decrease in other current liabilities-27982.0807877.0-723230.0228294.0-352000.0332000.0
(Increase) Decrease in other working capital6 M547707.078708.035710.0-194142.0-17000.0228000.0
(Increase) Decrease in payables2 M-78000.0
(Increase) Decrease in receivables-85898.0-148308.0285653.0-5 M5 M-2 M2 M-776394.0345000.0506000.0
CapitalExpenditureReported152750.0108268.023527.0105765.0107466.010905.029305.0285948.055000.08000.0
Cash at beginning of period25 M14 M24 M12 M12 M14 M14 M31 M41 M12 M
Cash at end of period14 M24 M12 M12 M14 M14 M31 M41 M12 M35 M
Cash flow-20 M-15 M-12 M-15 M-12 M-20 M-22 M-22 M-23 M-28 M
CashFlowFromContinuingInvestingActivities-182791.0-137560.0-51350.02 M-107466.0-10905.0-29305.0-285948.0-20 M20 M
ChangeInAccountPayable2 M-78000.0
ChangeInPayablesAndAccruedExpense-3 M-664505.01 M-384641.0-2 M1 M-1 M182855.02 M-78000.0
ChangeInPrepaidAssets70190.0-215116.0245828.0-915222.0475077.0-2 M286391.0-348600.0-1 M777000.0
ChangeInWorkingCapital-3 M-1 M2 M132297.04 M-2 M209779.0-907987.0391000.02 M
ChangesInAccountReceivables-85898.0-5 M5 M
Depreciation163501.0180411.0162233.090768.095375.0485574.0446187.0452065.0
Depreciation unreconciled163501.0180411.0162233.090768.095375.0485574.0446187.0452065.0392000.0403000.0
DepreciationAndAmortization163501.0180411.0162233.090768.095375.0485574.0446000.0452000.0
Effect of exchange rate changes-252249.01 M-409163.0-102584.0592330.0-650427.0-604505.0-253250.02 M-522000.0
FinancingCashFlow9 M24 M956133.013 M13 M21 M40 M33 M12 M32 M
Free cash flow-20 M-15 M-12 M-15 M-12 M-20 M-22 M-22 M-23 M-28 M
GainLossOnInvestmentSecurities13 M-3 M-17117.0
IncomeTaxPaidSupplementalData136163.015728.05448.012080.034959.046000.0
Issuance of capital stock9 M24 M956133.012 M13 M18 M38 M33 M13 M32 M
IssuanceOfCapitalStock9 M24 M956133.012 M13 M18 M38 M33 M13 M32 M
IssuanceOfDebt-447497.0-460724.0-365510.0-381000.0-407000.0
Net cash from financing activities9 M24 M956133.013 M13 M21 M40 M33 M12 M32 M
Net cash from investing activities-182791.0-137560.0-51350.02 M-107466.0-10905.0-29305.0-285948.0-20 M20 M
Net cash from operating activities-20 M-15 M-12 M-15 M-12 M-20 M-22 M-22 M-23 M-28 M
Net change in cash & cash equivalents-11 M10 M-12 M-198163.02 M448140.018 M10 M-32 M24 M
Net income from continuing operations-19 M-14 M-15 M-16 M-17 M-33 M-23 M-26 M-25 M-28 M
NetCapitalExpenditureDisposals-55000.0-8000.0
NetCommonStockIssuance9 M24 M956133.012 M13 M18 M38 M33 M13 M32 M
NetForeignCurrencyExchangeGainLoss448926.0-893854.0203402.0-76235.0-359806.0353189.0645078.0425681.0-2 M282000.0
NetInvestmentPropertiesPurchaseAndSale-30041.0-29292.0-27823.02 M-20 M20 M
NetInvestmentPurchaseAndSale-30041.0-29292.0-27823.02 M-20 M20 M
NetIssuancePaymentsOfDebt-447497.0-460724.0-365510.0-381000.0-407000.0
NetLongTermDebtIssuance-447497.0-460724.0-365510.0-381000.0-407000.0
NetPPEPurchaseAndSale-152750.0-108268.0-23527.0-105765.0-107466.0-10905.0-29305.0-285948.0-55000.0-8000.0
Operating (gains) losses448926.0-893854.0203402.0-76235.0-359806.013 M-3 M408564.0-2 M282000.0
Other non-cash items75777.094817.068526.091727.02 M-3 M
ProceedsFromStockOptionExercised343440.0124955.03 M2 M469396.012000.0781000.0
Purchase of Float term investments-20 M
PurchaseOfInvestment-20 M
PurchaseOfPPE-152750.0-108268.0-23527.0-105765.0-107466.0-10905.0-29305.0-285948.0-55000.0-8000.0
Repayment of debt-447497.0-460724.0-365510.0-381000.0-407000.0
RepaymentOfDebt-447497.0-460724.0-365510.0-381000.0-407000.0
Sale of short term investments20 M
SaleOfInvestment2 M20 M
StockBasedCompensation980325.0429537.0406078.0578703.01 M1 M3 M4 M2 M2 M
UnrealizedGainLossOnInvestmentSecurities20000.0-5 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University